Index Fund Advisors Inc. Purchases New Position in Zoetis Inc. $ZTS

Index Fund Advisors Inc. acquired a new position in Zoetis Inc. (NYSE:ZTS) during the second quarter, Holdings Channel reports. The institutional investor acquired 3,980 shares of the company’s stock, valued at approximately $621,000.

Several other large investors also recently added to or reduced their stakes in ZTS. Sound Income Strategies LLC lifted its stake in shares of Zoetis by 54.3% in the 2nd quarter. Sound Income Strategies LLC now owns 432 shares of the company’s stock valued at $67,000 after purchasing an additional 152 shares during the last quarter. Tandem Investment Advisors Inc. raised its holdings in Zoetis by 100.3% during the first quarter. Tandem Investment Advisors Inc. now owns 395,626 shares of the company’s stock valued at $65,140,000 after buying an additional 198,089 shares in the last quarter. Canoe Financial LP lifted its position in shares of Zoetis by 859.0% in the second quarter. Canoe Financial LP now owns 13,369 shares of the company’s stock worth $2,085,000 after buying an additional 11,975 shares during the last quarter. Strs Ohio bought a new stake in shares of Zoetis during the 1st quarter worth about $22,891,000. Finally, Soros Capital Management LLC increased its holdings in shares of Zoetis by 32.0% during the 1st quarter. Soros Capital Management LLC now owns 17,441 shares of the company’s stock valued at $2,872,000 after acquiring an additional 4,230 shares during the last quarter. 92.80% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

ZTS has been the subject of a number of recent analyst reports. Piper Sandler upped their target price on Zoetis from $210.00 to $215.00 and gave the stock an “overweight” rating in a research report on Monday, August 11th. Stifel Nicolaus downgraded shares of Zoetis from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $165.00 to $160.00 in a report on Wednesday, June 18th. Leerink Partnrs lowered shares of Zoetis from a “strong-buy” rating to a “hold” rating in a research note on Thursday, July 17th. Argus reissued a “buy” rating and set a $190.00 target price on shares of Zoetis in a research report on Tuesday, September 9th. Finally, Leerink Partners cut shares of Zoetis from an “outperform” rating to a “market perform” rating and decreased their price target for the company from $180.00 to $155.00 in a report on Thursday, July 17th. Four analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $196.71.

Zoetis Trading Down 1.6%

Shares of ZTS stock opened at $141.05 on Monday. The firm has a market capitalization of $62.51 billion, a P/E ratio of 24.28, a price-to-earnings-growth ratio of 2.26 and a beta of 0.90. Zoetis Inc. has a 1 year low of $139.34 and a 1 year high of $196.55. The firm’s fifty day simple moving average is $149.24 and its 200 day simple moving average is $154.33. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 1.05.

Zoetis (NYSE:ZTS) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $1.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.14. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. The company had revenue of $2.46 billion for the quarter, compared to analyst estimates of $2.41 billion. During the same period last year, the business posted $1.56 EPS. The business’s quarterly revenue was up 4.2% on a year-over-year basis. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, sell-side analysts predict that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 2nd. Shareholders of record on Friday, October 31st will be issued a $0.50 dividend. The ex-dividend date of this dividend is Friday, October 31st. This represents a $2.00 annualized dividend and a yield of 1.4%. Zoetis’s dividend payout ratio is 34.42%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.